Envision Pharma Group has hired clinical research veteran Nick Jones as president of its Envision Medical Communications (EMC) business.
Jones will lead the EMC unit, which works with biopharma and medtech companies across areas including medical affairs, commercialization, market access and more. A specific focus for Jones will be integrating Envision's tech and AI capabilities into its portfolio of solutions and services, according to an April 8 release.
He brings a deep clinical research background, including stints at ConcertAI, where he served as SVP and GM of commercial solutions, as well as more than 10 years at CRO and consultancy firm IQVIA.
“Nick brings deep expertise, global market insight, and a shared ambition to build a world-class, tech-enabled pharma services organization," said Tom Langan, CEO of Envision Pharma Group. "His broad experience in technology and consulting will benefit both Envision and our clients. This is yet another step in our evolution as we strive to execute with precision and exceed client expectations."